{"id":10693,"date":"2026-10-17T01:32:24","date_gmt":"2026-10-16T22:32:24","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=10693"},"modified":"2026-10-17T01:32:24","modified_gmt":"2026-10-16T22:32:24","slug":"the-liver-for-the-cardiologist-beyond-fatty-liver","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/the-liver-for-the-cardiologist-beyond-fatty-liver\/","title":{"rendered":"The Liver for the Cardiologist: Beyond Fatty Liver"},"content":{"rendered":"<p>The Liver for the Cardiologist: Beyond Fatty Liver<\/p>\n<p>\u2022\u2060 \u2060From CKM to CKML: a proposed term discussed in JACC, adding liver care\u2014particularly MASLD (fatty liver associated with metabolic risk factors such as obesity, diabetes, hypertension, high triglycerides, or low HDL)\u2014to cardiovascular, kidney, and metabolic care.<\/p>\n<p>\u2022\u2060 \u2060MASLD is fatty liver associated with metabolic risk factors, such as obesity, diabetes, hypertension, high triglycerides, or low HDL; a JACC article discusses the proposed term CKML to include liver care alongside cardiovascular, kidney, and metabolic care.<\/p>\n<p>\u2022\u2060 \u2060FIB-4: a phone-accessible calculator using age, AST, ALT, and platelets to estimate advanced liver fibrosis risk.<\/p>\n<p>\u2022\u2060 \u2060Elevated FIB-4 score \u2192 Assessment with Scan and\/or hepatology referral, as indicated.<\/p>\n<p>Source : Nature Reviews G&amp;H\u2060 \u2022 Sep 2026<\/p>\n<p><a href=\"https:\/\/www.nature.com\/articles\/s41575-026-01255-z\u2060\">https:\/\/www.nature.com\/articles\/s41575-026-01255-z\u2060<\/a><\/p>\n<p><a href=\"https:\/\/doi.org\/10.1016\/j.jacc.2026.05.043\u2060\">https:\/\/doi.org\/10.1016\/j.jacc.2026.05.043\u2060<\/a><\/p>\n<p>FIB-4 calculator:<\/p>\n<p><a href=\"https:\/\/www.mdcalc.com\/calc\/2200\/fibrosis4-fib-4-index-liver-fibrosis\">https:\/\/www.mdcalc.com\/calc\/2200\/fibrosis4-fib-4-index-liver-fibrosis<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Liver for the Cardiologist: Beyond Fatty Liver \u2022\u2060 \u2060From CKM to CKML: a proposed term discussed in JACC, adding liver care\u2014particularly MASLD (fatty liver associated with metabolic risk factors such as obesity, diabetes, hypertension, high triglycerides, or low HDL)\u2014to cardiovascular, kidney, and metabolic care. \u2022\u2060 \u2060MASLD is fatty liver associated with metabolic risk factors, [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10693","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=10693"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10693\/revisions"}],"predecessor-version":[{"id":10694,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10693\/revisions\/10694"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=10693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=10693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=10693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}